• Tumor focality in prostate cancer: implications for focal therapy. Karavitakis M, Ahmed HU, Abel PD, Hazell S, Winkler MH. Nat Rev Clin Oncol. 2011 Jan;8(1):48-55
• Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy. Karavitakis M, Winkler M, Abel P, Livni N, Beckley I, Ahmed HU. Prostate Cancer Prostatic Dis. 2011 Mar;14(1):46-52
• Margin status after laparoscopic radical prostatectomy and the index lesion: implications for preoperative evaluation of tumor focality in prostate cancer. Karavitakis M, Ahmed HU, Abel PD, Hazell S, Winkler MH. J Endourol. 2012 May;26(5):503-8
• Trends in pathologic outcomes after introduction of active surveillance in the UK: implication for focal therapy. Karavitakis M, Ahmed HU, Abel PD, Livni N, Hazell S, Winkler MH. Prostate. 2012 Sep 15;72(13):1464-8
• Focal therapy for prostate cancer: opportunities and uncertainties. Karavitakis M, Winkler MH, Abel PD, Hazell S, Ahmed HU.Discov Med. 2011 Sep;12(64):245-55.
• Pattern of somatostatin receptors expression in normal and bladder cancer tissue samples. Karavitakis M, Msaouel P, Michalopoulos V, Koutsilieris M.Anticancer Res. 2014 Jun;34(6):2937-42
• Evaluation of sexual function in hypertensive men receiving treatment: a review of current guidelines recommendation. Karavitakis M, Komninos C, Theodorakis PN, Politis V, Lefakis G, Mitsios K, Koritsiadis S, Doumanis G. J Sex Med. 2011 Sep;8(9):2405-14